⌘K

Home/Filings/4/0001181431-10-053870

4//SEC Filing

Bartizal Ken 4

Accession 0001181431-10-053870

CIK 0001356857other

View on SEC.gov Company Profile

Filed

Nov 4, 8:00 PM ET

Accepted

Nov 5, 8:12 PM ET

Size

7.7 KB

Accession

0001181431-10-053870

Insider Transaction Report

Form 4

Period: 2010-11-03

Trius Therapeutics IncTSRX

Chief Development Officer

Transactions

Award
Stock Option (right to buy)
2010-11-03+10,000→ 10,000 total
Exercise: $3.50Exp: 2020-11-02→ Common Stock (10,000 underlying)
Award
Stock Option (right to buy)
2010-11-03+30,000→ 30,000 total
Exercise: $3.50Exp: 2020-11-02→ Common Stock (30,000 underlying)

Footnotes (2)

[F1]The option vests in 48 successive equal monthly installments over the four year period beginning on November 1, 2010.
[F2]The option vests in 12 successive equal monthly installments over the one year period beginning on November 1, 2010.

Documents

1 file

4
rrd290236.xmlPrimary
FORM 4

Issuer

Trius Therapeutics Inc

CIK 0001356857

Entity typeother

Related Parties

1

filerCIK 0001478832

Filing Metadata

Form type: 4
Filed: Nov 4, 8:00 PM ET
Accepted: Nov 5, 8:12 PM ET
Size: 7.7 KB

View on SEC.gov